The potential of radioiodinated (-)-m-iodovesamicol for diagnosing cholinergic deficit dementia

Citation
K. Shiba et al., The potential of radioiodinated (-)-m-iodovesamicol for diagnosing cholinergic deficit dementia, NUCL MED BI, 28(3), 2001, pp. 261-264
Citations number
24
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
28
Issue
3
Year of publication
2001
Pages
261 - 264
Database
ISI
SICI code
0969-8051(200104)28:3<261:TPOR(F>2.0.ZU;2-R
Abstract
We investigated changes in the brain distribution of (-)-[I-125]-m-iodovesa micol [(-)-[I-125]mIV] in cholinergic denervation rats produced by a unilat eral lesion of the nucleus basalis magnocellularis (NBM). Dual-tracer ex vi vo autoradiographic analysis using (-)-[I-125]mIV and [Tc-99m]HMPAO was con ducted to the effect of regional cerebral perfusion on the brain distributi on of (-)-[I-125]mIV in a unilateral NBM-lesioned rat. (-)-[I-125]mIV bindi ng in the ipsilateral cortex to the lesion significantly reduced by 10.4 %, compared with that in the contralateral cortex, while (-)-[I-125]mIV bindi ng in the ipsilateral caudate putamen, hippocampus and thalamus did not cha nge. The rate of reduction in the (-)-[I-125]mIV binding (10.4 %) was signi ficantly higher than that of [Tc-99m]HMPAO accumulation (4.0%) in the ipsil ateral cortex to the lesion (P < 0.01). These results suggested that radioi odinated (-)-mIV may be useful in the study of dementia characterized by de generation of the cholinergic neurotransmitter system, such as Alzheimer's disease. (C) 2001 Elsevier Science Inc. All rights reserved.